Todos os posts
Revisão sistemática | Produtos feitos à base de Cannabis para dor crônica.
14 Jun, 2022 | 13:24hCannabis-Based Products for Chronic Pain: A Systematic Review – Annals of Internal Medicine
Resumo dos anais em vídeo: Cannabis-Based Products for Chronic Pain: A Systematic Review
Resumo para pacientes: Cannabis-Based Products for Chronic Pain
Conteúdos relacionados:
Podcast: #338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders
M-A: Birth outcomes of neonates exposed to marijuana in utero.
Cannabis-related allergies: an international overview and consensus recommendations.
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Review: Considerations for cannabinoids in perioperative care by anesthesiologists.
Review: Cannabis-based Medicines and the Perioperative Physician
Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know
Combinação de infusões de anticorpos anti-HIV suprimem o vírus por período prolongado.
14 Jun, 2022 | 13:21hComunicado de imprensa: Combination anti-HIV antibody infusions suppress virus for prolonged period – National Institutes of Health
Estudo original: Combination anti-HIV antibodies provide sustained virological suppression – Nature
Comentários no Twitter
Still don't get the enthusiasm for HIV Rx with bNAbs.
Compared to existing antivirals, they have:
– more baseline resistance
– the need to scale up new resistance tests
– more resource requirements (IV administration)
– … and, if like other monoclonals, $$$
What am I missing? https://t.co/7WZmIjutwE— Paul Sax (@PaulSaxMD) June 1, 2022
This is a wonderful advance.
"Our data demonstrate that combination therapy with broadly neutralizing monoclonal antibodies can provide long-term virological suppression without antiretroviral therapy in individuals with HIV"https://t.co/DKNVSlg3mC
— Michael Worobey (@MichaelWorobey) June 2, 2022
Revisão de escopo | Consequências não intencionais das medidas implementadas no ambiente escolar para conter a pandemia de COVID-19.
14 Jun, 2022 | 13:20hResumo: Unintended consequences of school-based measures to manage the COVID-19 pandemic – Cochrane Library
Avaliação prospectiva da disfunção autonômica em pacientes com sequela pós-aguda de COVID-19.
14 Jun, 2022 | 13:18hComentário: Autonomic Dysfunction in Post-Acute Sequela of COVID-19 – American College of Cardiology
Metanálise com dados de pacientes individuais | Indicadores prognósticos e desfechos de pacientes internados por COVID-19 com doença neurológica.
14 Jun, 2022 | 13:17hPredição da resposta a fluidos. Quais são as novidades?
14 Jun, 2022 | 13:15hPrediction of fluid responsiveness. What’s new? – Annals of Intensive Care
Revisão das evidências | Preparo para uma cirurgia com mudanças de estilo de vida.
14 Jun, 2022 | 13:14hPreparing for an operation with lifestyle changes – Evidently Cochrane
Posicionamento científico ANMCO sobre tratamento antitrombótico de pacientes com fibrilação atrial submetidos a colocação de stent coronariano e/ou com síndromes coronarianas agudas.
14 Jun, 2022 | 13:12hRecomendações para exames de imagem cardiovascular multimodalidade para pacientes com cardiomiopatia hipertrófica.
14 Jun, 2022 | 13:11hEstudo randomizado | Efeitos da azitromicina sobre doença pulmonar estrutural em bebês com fibrose cística.
14 Jun, 2022 | 13:10hThe effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial – The Lancet Respiratory Medicine (link para o resumo – $ para o texto completo)